88 related articles for article (PubMed ID: 202695)
1. Effects of L-dopa, GPA 1734 and other agents on basement membrane biosynthesis.
Maragoudakis ME; Kalinsky HJ; Wasvary J
J Pharmacol Exp Ther; 1978 Feb; 204(2):372-83. PubMed ID: 202695
[No Abstract] [Full Text] [Related]
2. Inhibition of basement membrane biosynthesis prevents angiogenesis.
Maragoudakis ME; Sarmonika M; Panoutsacopoulou M
J Pharmacol Exp Ther; 1988 Feb; 244(2):729-33. PubMed ID: 2450202
[TBL] [Abstract][Full Text] [Related]
3. A benzo[a]quinolizine derivative with a neuroleptic-like action on cerebral monoamine turnover.
Saner A; Pletscher A
J Pharmacol Exp Ther; 1977 Dec; 203(3):556-63. PubMed ID: 21955
[No Abstract] [Full Text] [Related]
4. [Ways of increasing resistance of renal transplant to thermal ischemia].
Savchenko NE; Skobeius IA; Soklakov VI; Pilotovich VS
Urol Nefrol (Mosk); 1977; (5):72-6. PubMed ID: 144344
[No Abstract] [Full Text] [Related]
5. Synthesis of potential antineoplastic agents XXVI: 1,3,4,6,7,11b-hexahydro-9,10-dimethoxy-2H-benzo[a]2-quinolizinone derivatives.
Popp FD; Watts RF
J Pharm Sci; 1978 Jun; 67(6):871-3. PubMed ID: 248062
[TBL] [Abstract][Full Text] [Related]
6. Rate of basement membrane biosynthesis as an index to angiogenesis.
Maragoudakis ME; Panoutsacopoulou M; Sarmonika M
Tissue Cell; 1988; 20(4):531-9. PubMed ID: 2467405
[TBL] [Abstract][Full Text] [Related]
7. Basement membrane biosynthesis as a target for developing inhibitors of angiogenesis with anti-tumor properties.
Maragoudakis ME; Missirlis E; Karakiulakis GD; Sarmonica M; Bastakis M; Tsopanoglou N
Kidney Int; 1993 Jan; 43(1):147-50. PubMed ID: 7679456
[TBL] [Abstract][Full Text] [Related]
8. Inhibitors of basement membrane collagen synthesis prevent endothelial cell alignment in matrigel in vitro and angiogenesis in vivo.
Haralabopoulos GC; Grant DS; Kleinman HK; Lelkes PI; Papaioannou SP; Maragoudakis ME
Lab Invest; 1994 Oct; 71(4):575-82. PubMed ID: 7526036
[TBL] [Abstract][Full Text] [Related]
9. Liver collagen hydroxylation in murine schistosomiasis.
Dunn MA; Maragoudakis ME; Hait PK
Biochim Biophys Acta; 1978 Jan; 538(2):328-33. PubMed ID: 202335
[TBL] [Abstract][Full Text] [Related]
10. Effect of Ro 4-1284 on audiogenic seizure susceptibility and intensity in epilepsy-prone rats.
Jobe PC; Brown RD; Dailey JW
Life Sci; 1981 May; 28(18):2031-8. PubMed ID: 6909499
[No Abstract] [Full Text] [Related]
11. Enhancement of 5-hydroxytryptamine synthesis in brain by monamine-depleting drugs.
Saner A; Pletscher A
J Pharm Pharmacol; 1978 Feb; 30(2):115-7. PubMed ID: 24096
[No Abstract] [Full Text] [Related]
12. Antitumor effect of GPA1734 in rat Walker 256 carcinoma.
Missirlis E; Karakiulakis G; Maragoudakis ME
Invest New Drugs; 1990 May; 8(2):145-7. PubMed ID: 2384301
[TBL] [Abstract][Full Text] [Related]
13. Release of norepinephrine and dopamine-beta-hydroxylase by nerve stimulation. V. Enhanced release associated with a granular effect of a benzoquinolizine derivative with reserpine-like properties.
Cubeddu LX; Weiner N
J Pharmacol Exp Ther; 1975 Jun; 193(3):757-75. PubMed ID: 239214
[TBL] [Abstract][Full Text] [Related]
14. Effects of Ro 4-1284 on electrically-induced spinal cord seizures and on spinal cord norepinephrine and 5-hydroxytryptamine levels.
Jobe PC; Ray TB; Geiger PF; Bourn WM
Res Commun Chem Pathol Pharmacol; 1977 Dec; 18(4):601-12. PubMed ID: 243955
[TBL] [Abstract][Full Text] [Related]
15. Basement membrane biosynthesis. Secretion without deposition of underhydroxylated basement membrane collagen by parietal yolk sacs.
Maragoudakis ME; Kalinsky HJ; Wasvary J
Biochim Biophys Acta; 1978 Jan; 538(1):139-54. PubMed ID: 202332
[No Abstract] [Full Text] [Related]
16. Depletion of epinephrine in rat hypothalamus by Ro 4-1284: influence of pargyline and harmaline.
Fuller RW; Hemrick-Luecke SK
Brain Res Bull; 1980; 5(5):589-91. PubMed ID: 6903452
[TBL] [Abstract][Full Text] [Related]
17. The effect of pargyline pretreatment on the enhancement of the exocytotic release of norepinephrine during nerve stimulation which is induced by a benzoquinolizine compound with reserpine-like properties.
Langley AE; Weiner N
J Pharmacol Exp Ther; 1980 Jun; 213(3):534-8. PubMed ID: 6907314
[TBL] [Abstract][Full Text] [Related]
18. Innately hearing impaired Sprague-Dawley rats exhibit audiogenic seizure susceptibility following monoamine depletion.
Reigel CE; Faingold CL
Proc West Pharmacol Soc; 1993; 36():267-71. PubMed ID: 8378388
[No Abstract] [Full Text] [Related]
19. Synthesis and antihypertensive activity of a series of spiro[1,3,4,6,7,11b-hexahydro-2H-benzo[a]quinolizine-2,5'-oxazolidin-2'-one]s.
Caroon JM; Clark RD; Kluge AF; Lee CH; Strosberg AM
J Med Chem; 1983 Oct; 26(10):1426-33. PubMed ID: 6312043
[TBL] [Abstract][Full Text] [Related]
20. Metabolism and efflux of [3H]dopamine in rat neostriatum: presynaptic origin of 3,4-[3H]dihydroxyphenylacetic acid.
Cubeddu LX; Hoffmann IS; Ferrari GB
J Pharmacol Exp Ther; 1979 May; 209(2):165-75. PubMed ID: 255152
[No Abstract] [Full Text] [Related]
[Next] [New Search]
